Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED)

Effect of the Transcranial Magnetic Stimulation Applied on the Left Dorsolateral Prefrontal Cortex on the Clinical and Neuropsychological Variables in Subjects With Binge Eating Disorder

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03540641

Acronym

TMS&BED

Enrollment

Registered

2018-05-30

Start date

2017-04-06

Completion date

2018-12-30

Last updated

2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge-Eating Disorder

Keywords

Binge Eating Disorder, Transcranial Magnetic Stimulation, Food Craving

Brief summary

This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.

Detailed description

Binge Eating Disorder (BED) affects a significant percentage of de national population (1.4%) in a portio 2-1 in woman compared with men, the repetitive Transcranial Magnetic Stimulation (rTMS) is a neuromodulation technique, which allows us to induce brain electrical activity by plating magnetic fields and it has been proven that at 10Hz it has an effect of improvement in the craving of food.

Interventions

DEVICEMagVenture MagPro R30

the subjects will receive 1500 or 5000 pulses at 5Hz

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

1. Subjects of both sexes. 2. Subjects from 18 to 45 years of age. 3. Subjects with diagnosis of binge eating disorder. 4. Subjects without changes in pharmacological treatment in the last 30 days. 5. Subjects who agree to sign the informed consent letter.

Exclusion criteria

1.Subjects with a history of traumatic brain injury with loss of consciousness. 2.Subjects with intracranial metallic objects or metal plates in the skull. 3.Subjects who suffer chronic diseases not controlled at the time of entering the study (for example: hypertension, diabetes, rheumatic diseases). 4.Patients with psychotic symptoms, bipolar affective disorders and substance dependence. 5.Subjects with alterations in electroencephalogram (epileptiform activity). 6.Patients with any type of chronic or neurological medical disease not controlled.

Design outcomes

Primary

Measure	Time frame	Description
Food Craving Inventory (FCI)	6 weeks	The FCI is a self-report inventory designed to measure the food craving, is made up of 37 elements and is a scale-likert instrument.

Secondary

Measure	Time frame	Description
Barratt Impulsivity Scale (BIS-11)	6 weeks	The Barratt Impulsiveness Scale is a questionnaire designed to assess the personality / behavioral construct of impulsiveness is composed of 30 items describing common impulsive or non-impulsive (for reversed scored items) behaviors and preferences .

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026